Healthcare provider profile · identity verified

Pervez A Khatib, MD

Family Practice · WOONSOCKET, RI · NPI 1881687481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	175
Lisinopril	Lisinopril	378	129
Omeprazole	Omeprazole	297	94
Albuterol Sulfate Hfa	Albuterol Sulfate	286	87
Amlodipine Besylate	Amlodipine Besylate	272	91
Gabapentin	Gabapentin	243	64
Levothyroxine Sodium	Levothyroxine Sodium	208	72
Metformin Hcl	Metformin Hcl	204	71
Trazodone Hcl	Trazodone Hcl	139	46
Hydrochlorothiazide	Hydrochlorothiazide	138	42
Losartan Potassium	Losartan Potassium	138	50
Simvastatin	Simvastatin	137	54
Sertraline Hcl	Sertraline Hcl	128	40
Metoprolol Tartrate	Metoprolol Tartrate	126	39
Tamsulosin Hcl	Tamsulosin Hcl	125	46
Pantoprazole Sodium	Pantoprazole Sodium	122	36
Rosuvastatin Calcium	Rosuvastatin Calcium	111	47
Furosemide	Furosemide	108	33
Montelukast Sodium	Montelukast Sodium	95	23
Meloxicam	Meloxicam	86	26
Metoprolol Succinate	Metoprolol Succinate	84	33
Fluticasone Propionate	Fluticasone Propionate	83	40
Atenolol	Atenolol	81	29
Eliquis	Apixaban	75	19
Pravastatin Sodium	Pravastatin Sodium	74	26
Ibuprofen	Ibuprofen	73	22
Lorazepam	Lorazepam	73	17
Clonazepam	Clonazepam	68	suppressed
Diclofenac Sodium	Diclofenac Sodium	66	28
Metformin Hcl Er	Metformin Hcl	66	22
Duloxetine Hcl	Duloxetine Hcl	63	16
Famotidine	Famotidine	61	18
Alprazolam	Alprazolam	57	17
Glipizide	Glipizide	57	19
Alendronate Sodium	Alendronate Sodium	53	15
Jardiance	Empagliflozin	52	17
Escitalopram Oxalate	Escitalopram Oxalate	50	20
Trulicity	Dulaglutide	49	suppressed
Glipizide Er	Glipizide	48	13
Chlorthalidone	Chlorthalidone	47	11
Triamcinolone Acetonide	Triamcinolone Acetonide	45	31
Mirtazapine	Mirtazapine	44	11
Bumetanide	Bumetanide	41	suppressed
Carvedilol	Carvedilol	41	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	22
Naproxen	Naproxen	39	17
Clopidogrel	Clopidogrel Bisulfate	38	14
Prednisone	Prednisone	38	29
Quetiapine Fumarate	Quetiapine Fumarate	37	11
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Bupropion Xl	Bupropion Hcl	35	11
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Spironolactone	Spironolactone	35	suppressed
Allopurinol	Allopurinol	34	suppressed
Glimepiride	Glimepiride	34	12
Oxybutynin Chloride	Oxybutynin Chloride	34	11
Mupirocin	Mupirocin	31	23
Pregabalin	Pregabalin	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	11
Nystatin	Nystatin	30	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	27	suppressed
Cephalexin	Cephalexin	27	25
Ezetimibe	Ezetimibe	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	25
Wixela Inhub	Fluticasone Propion/Salmeterol	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Ozempic	Semaglutide	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	16
Methocarbamol	Methocarbamol	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	12
Amoxicillin	Amoxicillin	22	18
Azithromycin	Azithromycin	22	20
Buspirone Hcl	Buspirone Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Ammonium Lactate	Ammonium Lactate	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Levofloxacin	Levofloxacin	16	15
Memantine Hcl	Memantine Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Valsartan	Valsartan	16	suppressed
Acyclovir	Acyclovir	15	12
Fluconazole	Fluconazole	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydrocortisone	Hydrocortisone	14	12
Lactulose	Lactulose	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error